staceywhite, Author at European Medical Journal - Page 19 of 195

Disease Burden and Care of Hyperkalaemia in Patients with T2DM-CKD

Chronic kidney disease (CKD) is a global public health problem with a high impact on morbidity and mortality. Diabetes is one of the…

Optimising Phosphate Removal

Hyperphosphataemia is a significant contributor to morbidity and mortality in patients undergoing haemodialysis. While dietary phosphate…

Inflammation and Hormonal Risk in Renal Replacement Therapy

Renal replacement therapy prolongs life in patients with Stage 5 chronic kidney disease. Сardiovascular diseases are the main cause of…

Managing Anaemia in Chronic Kidney Disease with Desidustat

Chronic kidney disease (CKD)-related anaemia is a common and debilitating complication, primarily due to a relative deficiency in…

Optimizing Board Exam Outcomes For Hematology/Oncology Fellows

Certification in Hematology and Oncology requires mastery of increasingly complex clinical knowledge. Despite this, approximately 8% of…

Novel Pharmacology Curriculum in Hematology-Oncology Fellowship Program

Thorough understanding of cancer therapeutics is a critical component of hematology–oncology (HO) training, with pharmacology…

Fertility Outcomes After Immunotherapy in Young Adults

Immune checkpoint inhibitors (ICI) are used to treat multiple types of cancer. However, there are limited studies on the long-term…

Survival Disparities in Epithelial Ovarian Cancer

Ovarian cancer represents a leading cancer-related cause of death among women in the USA, with approximately 20,890 new cases expected to…

Navigators and Racial Literacy in Cervical Cancer Care

Cervical cancer is the third most prevalent cancer in Brazilian women. Around 17,000 new cases are expected for Brazil’s 2023–2025…

EULAR 2025 Interview: Rikke Helene Moe

Rikke Helene Moe – EULAR VP HPR, Senior Researcher at Health Services Research and Innovation Unit (EHI); Center for treatment of…